Protalix BioTherapeutics Inc (FRA:PBDA)
€ 2 +0.042 (+2.15%) Market Cap: 162.78 Mil Enterprise Value: 135.63 Mil PE Ratio: 10.17 PB Ratio: 2.64 GF Score: 56/100

Protalix BioTherapeutics Inc (FRA:PBDA) Transcripts

  • 1